Establishing safety and regulatory requirements for compounded medications.

Summary

The bill creates new safety rules for compounded medications, demanding that any bulk drug substance used meet United States Pharmacopeia standards, be pharmaceutical grade, have a valid certificate of analysis, and come from an FDA‑registered facility inspected within the past two years. It applies to anyone who sells, transfers, or distributes compounded drugs and gives the state pharmacy commission authority to inspect, require records, and enforce penalties of $1,000 per dose and possible license revocation. The measure aims to protect patients from substandard or contaminated ingredients, especially those imported from foreign sources.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share